KARBE FRANK - Insider Non-Derivative Transactions at Cidara Therapeutics, Inc. (CDTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 10, 2025, KARBE FRANK's relationship to Cidara Therapeutics, Inc. (CDTX) is Officer (Chief Financial Officer), and currently has 50,562 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CDTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

KARBE FRANK - Insider Non-Derivative Transactions of CDTX Common Stock

KARBE FRANK - Insider Non-Derivative Transactions at CDTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 11, 2025	F -- (Common Stock)	7290	219.6	50562
Feb 25, 2025	Acquisition -- (Common Stock)	57500	0	57500